Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
3 Beaten-Down Stocks to Buy and Hold
09:53am, Saturday, 15'th Oct 2022
These stocks could be ready for big bounces.
The Importance Of Government Contracting For Pfizer And Moderna
09:53pm, Friday, 14'th Oct 2022
COVID-19 vaccine Comirnaty and Paxlovid pill should contribute circa 55% to Pfizer's 2022 revenues. Pfizer's revenues from the U.S. government represented 26% of total revenues for Q2 2022, up from 13
FDA Allows Emergency Use of Omicron-Based COVID Jabs in Kids
05:16am, Friday, 14'th Oct 2022
Anticipating a surge of COVID-19 infections later this year, the FDA broadens the label of authorized Omicron-based BA.4/BA.5 adapted bivalent boosters to include children as young as five years.
Merck And Moderna Move Forward With Melanoma Vaccine - There's A Case For Backing Both
04:37pm, Thursday, 13'th Oct 2022
Back in September 2021,Moderna's and Merck's market cap valuation were only a few billions apart at ~$175bn and ~$182bn, respectively. As the more diversified, future-proofed pharma, it makes sense th
Moderna (MRNA) Up After Merck Exercises Option for Cancer Jab
12:48pm, Thursday, 13'th Oct 2022
Merck (MRK) exercises an option to jointly develop and commercialize Moderna's (MRNA) personalized cancer vaccine as part of an existing collaboration agreement between the companies.
Moderna to Report Third Quarter 2022 Financial Results on Thursday, November 3, 2022
08:00am, Thursday, 13'th Oct 2022
CAMBRIDGE, MA / ACCESSWIRE / October 13, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live
Moderna (MRNA) Soars 8.3%: Is Further Upside Left in the Stock?
07:32am, Thursday, 13'th Oct 2022
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Moderna Now Priced Attractively For Long-Term Investors
07:30am, Thursday, 13'th Oct 2022
Moderna's revenue is declining as public resists boosting. The FDA approved the new booster for children aged 6 and up.
Moderna and Merck ink US$250mln deal to develop world's first cancer vaccine
03:42am, Thursday, 13'th Oct 2022
The group that developed a Covid jab using messenger RNA (mRNA) technology has inked a US$250mln deal with to create a cancer vaccine with one of the world's largest pharma companies. Moderna Theraput
These 2 Stocks Gave Investors a Nice Surprise Wednesday
07:16pm, Wednesday, 12'th Oct 2022
Markets moved slightly lower in advance of the latest data on inflation.
Moderna and Merck enter joint venture to develop cancer vaccine
06:40pm, Wednesday, 12'th Oct 2022
Yahoo Finance anchors Seana Smith and Dave Brigs discuss pharmaceutical manufacturers Moderna and Merck are partnering together to develop a cancer vaccine.
Moderna to develop a personalized cancer vaccine with Merck
04:21pm, Wednesday, 12'th Oct 2022
Michael Yee, Jefferies managing director, joins 'Closing Bell' to share details on the Moderna and Merck announcement about a personalized cancer treatment for people with melanoma and what it means f
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
03:47pm, Wednesday, 12'th Oct 2022
The move is welcomed by investors because if successful, it would help Moderna diversify its revenue and profits away from COVID-19 vaccines.
Moderna shares jumped 15% on Wednesday: this is why
03:29pm, Wednesday, 12'th Oct 2022
Shares of Moderna Inc (NASDAQ: MRNA) jumped as much as 15% this morning after the biotechnology company built on an agreement it signed with Merck & Co Inc (NYSE: MRK) in 2016.
CDC officially recommends new boosters for young children
02:47pm, Wednesday, 12'th Oct 2022
The Centers for Disease Control and Prevention officially signed off on allowing children as young as 5 years old to get an updated COVID-19 booster shot. CDC Director Rochelle Walensky signed the dec
